2023
DOI: 10.1158/2326-6066.cir-23-0667
|View full text |Cite
|
Sign up to set email alerts
|

Let the Guard Down: cAMP Activators Can Improve Immunotherapy in GBM

Juyeun Lee,
Kristen E. Kay,
Michael A. Vogelbaum
et al.

Abstract: Enhancing T-cell infiltration into glioblastoma (GBM) tumors has proven challenging yet remains crucial for improving the efficacy of immunotherapy for patients with this deadly cancer. In this issue, Qin, Huang, Li, and colleagues find that inhibiting vasculature formation driven by cancer stem cells is a promising target to enhance immunotherapy in GBM. See related article by Qin, Huang, Li, et al., p. 1351 (2).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 5 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?